Incyte Corp (INCY)
75.95
+0.20
(+0.26%)
USD |
NASDAQ |
Nov 05, 09:53
Incyte Total Liabilities (Quarterly): 1.841B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.841B |
| June 30, 2024 | 1.665B |
| March 31, 2024 | 1.741B |
| December 31, 2023 | 1.592B |
| September 30, 2023 | 1.457B |
| June 30, 2023 | 1.468B |
| March 31, 2023 | 1.335B |
| December 31, 2022 | 1.471B |
| September 30, 2022 | 1.284B |
| June 30, 2022 | 1.234B |
| March 31, 2022 | 1.191B |
| December 31, 2021 | 1.163B |
| September 30, 2021 | 1.050B |
| June 30, 2021 | 968.76M |
| March 31, 2021 | 933.59M |
| December 31, 2020 | 949.65M |
| September 30, 2020 | 916.60M |
| June 30, 2020 | 867.72M |
| March 31, 2020 | 814.70M |
| December 31, 2019 | 828.34M |
| September 30, 2019 | 792.29M |
| June 30, 2019 | 700.44M |
| March 31, 2019 | 668.59M |
| December 31, 2018 | 719.80M |
| September 30, 2018 | 717.05M |
| Date | Value |
|---|---|
| June 30, 2018 | 664.23M |
| March 31, 2018 | 677.97M |
| December 31, 2017 | 671.95M |
| September 30, 2017 | 616.55M |
| June 30, 2017 | 612.61M |
| March 31, 2017 | 641.41M |
| December 31, 2016 | 1.219B |
| September 30, 2016 | 1.174B |
| June 30, 2016 | 1.121B |
| March 31, 2016 | 876.19M |
| December 31, 2015 | 836.28M |
| September 30, 2015 | 843.20M |
| June 30, 2015 | 875.16M |
| March 31, 2015 | 904.04M |
| December 31, 2014 | 878.10M |
| September 30, 2014 | 874.86M |
| June 30, 2014 | 850.10M |
| March 31, 2014 | 829.25M |
| December 31, 2013 | 822.68M |
| September 30, 2013 | 328.61M |
| June 30, 2013 | 362.00M |
| March 31, 2013 | 493.81M |
| December 31, 2012 | 505.38M |
| September 30, 2012 | 516.48M |
| June 30, 2012 | 529.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
814.70M
Minimum
Mar 2020
1.841B
Maximum
Sep 2024
1.239B
Average
1.213B
Median
Total Liabilities (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | 42.61M |
| Merck & Co Inc | 68.98B |
| Pfizer Inc | 128.22B |
| Biomarin Pharmaceutical Inc | 1.438B |
| Allogene Therapeutics Inc | 131.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.012B |
| Shareholders Equity (Quarterly) | 3.171B |
| Current Ratio | 1.870 |